Empagliflozin and Metformin Hydrochloride Tablets – Comprehensive Solution for Diabetes and Heart He

Effective management of type 2 diabetes requires medications that not only control blood glucose levels but also support cardiovascular health and long-term well-being. GLIEMPAFLOZIN MET ER, combining Empagliflozin 25 mg and Metformin Hydrochloride Extended Release 1000 mg, is designed to provide comprehensive glycemic control while improving patient adherence with convenient once-daily dosing.

Introduction: What is GLIEMPAFLOZIN MET ER?

GLIEMPAFLOZIN MET ER is a dual-action oral medication that combines Empagliflozin, an SGLT2 inhibitor, and Metformin Hydrochloride Extended Release (ER), a biguanide antidiabetic agent. This combination works synergistically to:

• Reduce fasting and postprandial blood glucose levels

• Improve insulin sensitivity

• Support cardiovascular and kidney health

The extended-release formulation of Metformin allows gradual absorption, reducing gastrointestinal side effects while maintaining steady therapeutic levels, making it ideal for long-term diabetes management.

Composition of GLIEMPAFLOZIN MET ER

Each tablet contains:

• Empagliflozin IP – 25 mg

• Metformin Hydrochloride IP (Extended Release) – 1000 m

• Excipients – q.s.

This formulation ensures consistent blood sugar control and patient safety.

Mechanism of Action

Empagliflozin (25 mg):

• Inhibits the SGLT2 protein in kidneys, preventing glucose reabsorption

• Increases urinary glucose excretion

• Supports weight reduction and reduces cardiovascular risks

Metformin Hydrochloride (ER 1000 mg):

• Suppresses hepatic glucose production

• Improves insulin sensitivity in peripheral tissues

• Provides controlled, gradual release to minimize stomach irritation

Together, these agents offer complementary mechanisms for effective management of type 2 diabetes.

Key Benefits of GLIEMPAFLOZIN MET ER

1. Comprehensive Blood Sugar Control: Targets fasting and post-meal glucose levels for consistent glycemic management.

2. Cardiovascular Protection: Empagliflozin helps reduce heart failure risk and supports heart health.

3. Improved Adherence: Extended-release formulation allows once-daily dosing, reducing pill burden.

4. Weight Management: Promotes mild weight reduction through glucose excretion.

5. Dual Mechanism Therapy: Combines insulin-independent and insulin-sensitizing actions for maximum efficacy.

6. Reduced Risk of Diabetes Complications: Helps prevent neuropathy, nephropathy, and retinopathy over time.

How to Take GLIEMPAFLOZIN MET ER

• Dosage: As prescribed by your doctor, usually once daily with meals.

• Administration: Swallow the tablet whole with water; do not crush or chew.

• Hydration: Maintain adequate fluid intake to support kidney function.

• Monitoring: Regular blood glucose monitoring and periodic kidney function tests are recommended.

Important: Do not adjust the dose without consulting your healthcare provider.

Who Should Use GLIEMPAFLOZIN MET ER?

• Adults with type 2 diabetes mellitus requiring combination therapy for improved glycemic control

• Patients who have inadequate blood sugar control with Metformin alon

• Individuals at risk for cardiovascular complications seeking added heart-protective benefits

• Patients who prefer convenient, once-daily oral therapy

Precautions and Safety Information

• Kidney Health: Not recommended in patients with severe renal impairment

• Lactic Acidosis: Rare but serious side effect of Metformin; report symptoms such as unusual fatigue, muscle pain, or breathing difficulty

• Hydration: Maintain adequate fluid intake to prevent dehydration

• Other Medications: Inform your doctor about other medications to avoid interactions

• Pregnancy & Lactation: Consult a physician before use

Possible Side Effects

Common side effects may include:

• Increased urination due to Empagliflozin

• Mild gastrointestinal discomfort, nausea, or diarrhea from Metformin

• Thirst, dry mouth

• Rarely, urinary tract or genital infections

Most side effects are mild and manageable with proper hydration and medical guidance. Severe reactions require immediate medical attention.

Why Choose Steris Healthcare for GLIEMPAFLOZIN MET ER?

Steris Healthcare Pvt. Ltd. is a trusted pharmaceutical company dedicated to patient well-being. Choosing GLIEMPAFLOZIN MET ER from Steris ensures:

• High-quality, GMP-certified manufacturing for safety and efficacy
  
  

• Reliable, accurate dosing for optimal therapeutic outcomes

• Patient-centric solutions supporting long-term adherence and health improvement

• Accessibility and affordability for patients managing chronic conditions

Steris Healthcare combines innovation and quality to deliver medications that patients and healthcare providers can trust.

Patient Perspective

From a patient’s viewpoint, GLIEMPAFLOZIN MET ER provides the convenience of once-daily dosing with improved blood sugar control. Patients report:

• Reduced fluctuations in blood glucose

• Support in managing weight and cardiovascular risk

• Simplified treatment regimen with fewer pills

• Enhanced overall quality of life

The combination therapy encourages adherence, reduces complications, and helps patients feel more in control of their diabetes management.

Frequently asked questions

Q1. What conditions does GLIEMPAFLOZIN MET ER treat?
It is prescribed for type 2 diabetes to control blood glucose levels and support cardiovascular health.

Q2. Can it be combined with other diabetes medications?
Yes, but only under the supervision of a healthcare provider to avoid hypoglycemia.

Q3. How should I take this tablet?
Once daily with meals, swallowed whole with water.

Q4. Are there dietary restrictions?
Maintain a balanced diet, adequate hydration, and avoid excessive alcohol consumption.

Q5. Can it be used in kidney-compromised patients?
Patients with severe renal impairment should avoid this medication; consult a doctor for alternatives.

Q6. Are regular check-ups necessary?
Yes, regular blood glucose monitoring and kidney function tests are recommended.

Conclusion

Empagliflozin 25mg & Metformin Hydrochloride ER 1000mg is a highly effective, convenient, and patient-friendly therapy for managing type 2 diabetes. Its dual mechanism ensures comprehensive blood sugar control, promotes weight management, and supports cardiovascular health.

With the trusted quality of Steris Healthcare Pvt. Ltd., patients can rely on safe, effective, and consistent medication for long-term diabetes management. This combination tablet simplifies treatment, improves adherence, and helps patients lead healthier lives.

For further information: